Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ASND

Ascendis Pharma A/S

May 08 • 04:00PM ET

238.66

-7.48 -3.04 %

Healthcare • Biotechnology • Denmark • Large • NASD

Peers: BMRN SRPT RYTM INSM IONS ALNY UTHR KRYS FOLD VKTX

| Held by: IBB TCAF SPDW FDG AFOS QQQJ MSSM MEDI TMSL ONEQ

Scroll to Statements

Index	-	P/E	26.90	EPS (ttm)	8.87	Insider Own	0.91%	Shs Outstand	62.11M	Perf Week	8.03%
Market Cap	14.65B	Forward P/E	21.62	EPS next Y	11.04	Insider Trans	0.00%	Shs Float	60.82M	Perf Month	-1.26%
Enterprise Value	15.02B	PEG	-	EPS next Q	1.42	Inst Own	113.03%	Short Float	6.01%	Perf Quarter	7.43%
Income	581.90M	P/S	14.57	EPS this Y	398.09%	Inst Trans	-50.00%	Short Ratio	5.10	Perf Half Y	20.69%
Sales	1.01B	P/B	26.37	EPS next Y	-16.00%	ROA	33.69%	Short Interest	3.65M	Perf YTD	11.92%
Book/sh	9.05	P/C	22.20	EPS next 5Y	-	ROE	325.80%	52W High	250.74 -4.82%	Perf Year	49.73%
Cash/sh	10.75	P/FCF	289.68	EPS past 3/5Y	27.03% 14.76%	ROIC	57.78%	52W Low	150.89 58.17%	Perf 3Y	150.64%
Dividend Est.	-	EV/EBITDA	1111.92	Sales past 3/5Y	147.23% 152.45%	Gross Margin	87.35%	Volatility	5.78% 3.95%	Perf 5Y	79.58%
Dividend TTM	-	EV/Sales	14.94	EPS Y/Y TTM	249.36%	Oper. Margin	-0.66%	ATR (14)	10.26	Perf 10Y	1384.20%
Dividend Ex-Date	-	Quick Ratio	0.72	Sales Y/Y TTM	155.14%	Profit Margin	57.88%	RSI (14)	54.37	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	1.00	EPS Q/Q	787.72%	SMA20	1.72%	Beta	0.41	Target Price	291.87
Payout	-	Debt/Eq	1.84	Sales Q/Q	171.53%	SMA50	3.05%	Rel Volume	0.93	Prev Close	246.14
Employees	-	LT Debt/Eq	0.79	Earnings	May 07 BMO	SMA200	12.64%	Avg Volume	716.79K	Price	238.66
IPO	Jan 28, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	5917.28% -7.64%	Trades		Volume	669,918	Change	-3.04%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)